1. Home
  2. List
Reference Patent

Reference - List

  • 13 Hits
  • Search Condition : Filter (MeSH = Programmed Cell Death 1 Receptor / metabolism)
Species Resource Title
Human and Animal Cells MKN7(RCB0999) , MKN45(RCB1001) , MKN74(RCB1002) , HGC-27(RCB0500) , NUGC-4(RCB1939) Effects of TRPV2 on the Expression of PD-L1 and Its Binding Ability to PD-1 in Gastric Cancer.
Human and Animal Cells TE-8(RCB2098) PD-L1-expressing cancer-associated fibroblasts induce tumor immunosuppression and contribute to poor clinical outcome in esophageal cancer.
Human and Animal Cells HUDEP-2(RCB4557) Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing.
Human and Animal Cells Sq-1979(RCB0284) An In Vivo Study of Local Administration of Low-dose Anti-PD-1 Antibody Using an Oral Cancer Cell Line.
Human and Animal Cells RAJI(RCB1647) PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity.
Human and Animal Cells JLS-V9(RCB2651) Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model.
Human and Animal Cells TE-1(RCB1894) Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
Human and Animal Cells MKN7(RCB0999) , MKN45(RCB1001) , MKN74(RCB1002) , HGC-27(RCB0500) , NUGC-4(RCB1939) ANO9 regulates PD-L2 expression and binding ability to PD-1 in gastric cancer.
Human and Animal Cells LM8(RCB1450) , Saos-2(RCB0428) , HOS(RCB0992), , 143B/TK^(-)neo^(R)(RCB0701) Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
Human and Animal Cells PC-9(RCB4455) Soluble PD-L1 with PD-1-binding capacity exists in the plasma of patients with non-small cell lung cancer.
Human and Animal Cells Huh-7 Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein.
Human and Animal Cells Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigens.
Mice RBRC00904 Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy.